NEL Psoriasis pathway

NameDownload link
Psoriasis HCD pathway (NEL) V1.4_ March 2024CLICK TO DOWNLOAD
High Cost Drug, Biologic, Anti-TNF, IL23, IL17, TYK2 Inhibitor,
Adalimumab, Certolizumab, Etanercept, Infliximab, Apremilast,
Dimethyl Fumarate, Bimekizumab, Brodalumab, Ixekizumab,
Secukinumab, Ustekinumab, Guselkumab, Risankizumab,
Tidrakizumab, Deucravacitini

This website is for healthcare professions only.

It is not for public use.